rs4646181

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001371415.1(ACE2):​c.2114+187G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00395 in 112,046 control chromosomes in the GnomAD database, including 2 homozygotes. There are 111 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0040 ( 2 hom., 111 hem., cov: 23)

Consequence

ACE2
NM_001371415.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.04

Publications

1 publications found
Variant links:
Genes affected
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS2
High Homozygotes in GnomAd4 at 2 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371415.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE2
NM_001371415.1
MANE Select
c.2114+187G>A
intron
N/ANP_001358344.1Q9BYF1-1
ACE2
NM_021804.3
c.2114+187G>A
intron
N/ANP_068576.1Q9BYF1-1
ACE2
NM_001386259.1
c.2114+187G>A
intron
N/ANP_001373188.1A0A7I2V4H0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE2
ENST00000252519.8
TSL:1 MANE Select
c.2114+187G>A
intron
N/AENSP00000252519.3Q9BYF1-1
ACE2
ENST00000427411.2
TSL:1
c.2114+187G>A
intron
N/AENSP00000389326.1Q9BYF1-1
ENSG00000285602
ENST00000649243.1
n.*1859+187G>A
intron
N/AENSP00000497489.1A0A3B3IT09

Frequencies

GnomAD3 genomes
AF:
0.00395
AC:
442
AN:
111994
Hom.:
2
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0136
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00114
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.00263
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00395
AC:
443
AN:
112046
Hom.:
2
Cov.:
23
AF XY:
0.00324
AC XY:
111
AN XY:
34244
show subpopulations
African (AFR)
AF:
0.0136
AC:
421
AN:
30871
American (AMR)
AF:
0.00113
AC:
12
AN:
10577
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2675
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000113
AC:
6
AN:
53174
Other (OTH)
AF:
0.00260
AC:
4
AN:
1538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00756
Hom.:
39
Bravo
AF:
0.00467

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.18
DANN
Benign
0.73
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4646181; hg19: chrX-15584189; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.